Pentagon temporarily rescinds guidance on testosterone screening for US troops
WASHINGTON — The Pentagon is temporarily rescinding recently published clinical guidance for a new, mandatory testosterone deficiency screening policy for service members aged 30 and older, a U.S. official told Reuters on Thursday. On Wednesday, the Pentagon posted the "Clinical Guidance for Health and Human Performance Optimization" on its website. By Thursday, the memo and an accompanying…
The Pentagon has temporarily withdrawn its recently released clinical guidance on a mandatory testosterone deficiency screening policy for service members aged 30 and older, according to a U.S. official. The Clinical Guidance for Health and Human Performance Optimization was initially posted on the Pentagon's website on Wednesday, but both the document and a statement from spokesperson Sean Parnell have since disappeared from the site.
The draft, published on September 2, 2026, has been paused for updates, though interim guidance remains in place. The policy would have outlined distinct screening pathways for testosterone deficiency for both men and women during their annual health assessments. The guidance was intended to boost military readiness by identifying and addressing hormonal and energy availability concerns.
Following its withdrawal, a "Page Not Found" banner now appears on the Pentagon and Defense Health Agency websites.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
